Skip to main content
. 2020 Jul 27;151:314–321. doi: 10.1016/j.radonc.2020.04.019
  • A.

    Oral tongue SCC, T2N0M0

Radical radiation therapy Agreement
  • B.

    Oral tongue SCC, T3N2bM0

Radical chemoradiation therapy Strong agreement
  • C.

    Laryngeal SCC, T4aN2bM0, with tracheostomy

Radical chemoradiation therapy Agreement
  • D.

    Hard palate adenoid cystic carcinoma, T2N0M0

50% radical radiation therapy, 47% surveillance No agreement
  • E.

    Sinonasal maxilla SCC T4aN1M0

Radical chemoradiation therapy Strong agreement